Newsroom

EATONTOWN, New Jersey--(BUSINESS WIRE)--Clinilabs (« Clinilabs LLC »), une organisation de recherche sous contrat (CRO) mondiale offrant une gamme complète de services et spécialisée dans le développement de médicaments et de dispositifs destinés au système nerveux central (SNC), a annoncé aujourd’hui la nomination du Dr Bob Dagher, au poste de CMO et du Dr Waqar Ahmed Siddiqui, au poste de chercheur principal de l'unité de recherche clinique (URC) de la société à Eatontown, dans le New Jersey....

EATONTOWN, Nueva Jersey--(BUSINESS WIRE)--Clinilabs («Clinilabs LLC»), una organización de investigación por contrato (CRO) internacional que ofrece servicios integrales y está especializada en el desarrollo de medicamentos y dispositivos para el sistema nervioso central (SNC), ha anunciado hoy los nombramientos de Bob Dagher , doctor en Medicina, como director médico, y de Waqar Ahmed Siddiqui , doctor en Medicina, como investigador principal de la Unidad de Investigación Clínica (CRU) de la e...

EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs („Clinilabs LLC“), ein weltweit tätiges Full-Service-Auftragsforschungsinstitut (CRO), das sich auf die Entwicklung von Arzneimitteln und Medizinprodukten für das zentrale Nervensystem (ZNS) spezialisiert hat, gab heute die Ernennung von Dr. Bob Dagher zum Chief Medical Officer sowie von Dr. Waqar Ahmed Siddiqui zum leitenden Prüfarzt der klinischen Forschungseinheit (CRU) des Unternehmens in Eatontown, New Jersey, bekannt. Dr. Dagher wird die strateg...

EATONTOWN, NEW JERSEY--(BUSINESS WIRE)--Clinilabs ("Clinilabs LLC"), un'organizzazione globale di ricerca a contratto a servizio completo (CRO) specializzata nello sviluppo di farmaci e dispositivi per il sistema nervoso centrale (CNS), ha annunciato oggi le nomine di Bob Dagher , M.D., in qualità di Chief Medical Officer (direttore sanitario) e Waqar Ahmed Siddiqui , M.D., in qualità di Principal Investigator (responsabile scientifico) della Clinical Research Unit dell'Azienda a Eatontown, New...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Datavault AI Inc. (NASDAQ: DVLT) between September 4, 2024 and October 30, 2025 inclusive (the “Class Period”). Datavault AI purportedly owns and operates data management platforms.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating the Allegations tha...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Alibaba Group Holding Limited (“Alibaba” or the “Company”) (NYSE: BABA) common stock between June 26, 2025 and June 24, 2026, inclusive (“the Class Period”). If you suffered a loss on your Alibaba investments, you have until October 5, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after...

HANOI, Vietnam--(BUSINESS WIRE)--Global IT corporation FPT has become an OpenAI Select Partner within the OpenAI Partner Network....

JACKSONVILLE, Fla.--(BUSINESS WIRE)--FIS has launched Digital One™ Commercial in APAC, a core-agnostic, composable commercial banking platform....

LAS VEGAS--(BUSINESS WIRE)--At Black Hat USA 2026, Zenity Labs today released new research demonstrating zero-click PleaseFix exploit chains across leading agentic browsers....

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Teladoc Health Inc. (“Teladoc” or the “Company”) (NYSE: TDOC) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TELADOC HEALTH INC. (TDOC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On July 29, 2025, the Company reported second quarter earnings, inc...